FDA Denies Accelerated Approval for ALS Drug FDA Denies Accelerated Approval for ALS Drug
The FDA has rejected Clene Nanomedicine ' s application for accelerated approval for the experimental drug ALS drug, CNM-Au8, citing insufficient evidence.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - December 21, 2023 Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery Source Type: news
Juul Seeks US Authorization for Its New Age-restricted Menthol Pods Juul Seeks US Authorization for Its New Age-restricted Menthol Pods
Juul Labs said on Tuesday it was seeking U.S. authorization for its new menthol-flavored pods, which require user age verification, to be used with its e-cigarette device...Reuters Health Information (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - December 20, 2023 Category: Drugs & Pharmacology Tags: Pharmacist Source Type: news
Sickle Cell CRISPR Therapy May Offer'Functional Cure'Sickle Cell CRISPR Therapy May Offer'Functional Cure '
Patients with severe sickle cell disease could soon be freed from vaso-occlusive crises after receiving an infusion of exa-cel, the first gene-editing therapy to use CRISPR technology.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - December 19, 2023 Category: Drugs & Pharmacology Tags: Hematology-Oncology Source Type: news
Compounders: Don't Listen to Bad Press on GLP-1s Compounders: Don't Listen to Bad Press on GLP-1s
The compounding industry is trying to quell misconceptions about its GLP-1 products, which prescribers can order while branded versions of the drugs are in short supply.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - December 15, 2023 Category: Drugs & Pharmacology Tags: Family Medicine/Primary Care Source Type: news
FDA Approves Implant for Glaucoma FDA Approves Implant for Glaucoma
An intracameral implant that releases travoprost into the eye over an extended period to lower intraocular pressure in glaucoma and ocular hypertension will be available commercially in early 2024.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - December 15, 2023 Category: Drugs & Pharmacology Tags: Ophthalmology Source Type: news
How to Choose the Most Appropriate Migraine Treatment How to Choose the Most Appropriate Migraine Treatment
With many medications to choose from, doctors need to weigh the pros and cons of each drug to decide on the best approach for the patient.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - December 14, 2023 Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery Source Type: news
EU Publishes Its First List Of More Than 300 Critical Medicines, Vaccines EU Publishes Its First List Of More Than 300 Critical Medicines, Vaccines
The European Commission published its first list of critical medicines, as part of a wider overhaul of laws governing the 136 billion euro ($148 billion) pharmaceuticals...Reuters Health Information (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - December 12, 2023 Category: Drugs & Pharmacology Tags: Family Medicine/Primary Care Source Type: news
US Consumer Group Seeks Stronger Warnings on Botox, Similar Treatments US Consumer Group Seeks Stronger Warnings on Botox, Similar Treatments
Consumer advocacy group Public Citizen on Tuesday filed a petition with the U.S. Food and Drug Administration seeking to require makers of Botox and several similar...Reuters Health Information (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - December 12, 2023 Category: Drugs & Pharmacology Tags: Dermatology Source Type: news
Low-Dose Naltrexone Falls Short for Fibromyalgia Low-Dose Naltrexone Falls Short for Fibromyalgia
Despite off-label use of naltrexone by some patients with fibromyalgia in clinical practice, data from a randomized trial showed no pain relief advantage with the drug over placebo.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - December 11, 2023 Category: Drugs & Pharmacology Tags: Rheumatology Source Type: news
What is the Latest on the Statin-Type 2 Diabetes Debate? What is the Latest on the Statin-Type 2 Diabetes Debate?
Recent reports continue the conversation about statins and new-onset diabetes.Medscape Education Clinical Briefs (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - December 8, 2023 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology Clinical Brief Source Type: news
Radioimmunotherapy Tops ASCT in R/R Follicular Lymphoma Radioimmunotherapy Tops ASCT in R/R Follicular Lymphoma
A new trial from Italy challenges a decades-old assumption that autologous stem cell transplant is more effective than radioimmunotherapy for consolidation after follicular lymphoma relapse.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - December 5, 2023 Category: Drugs & Pharmacology Tags: Hematology-Oncology Source Type: news
Long-Acting PrEP in Europe's Fight Against HIV Long-Acting PrEP in Europe's Fight Against HIV
Europe ' s advances in HIV prevention strategies, including PrEP and long-acting retrovirals, bring hope amidst persistent access challenges and disparities.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - December 1, 2023 Category: Drugs & Pharmacology Tags: HIV/AIDS News Source Type: news
ASCO Details How to Manage Ongoing Cancer Drug Shortage ASCO Details How to Manage Ongoing Cancer Drug Shortage
The guidance also recommends counseling to help patients and providers who are struggling with ' psychological or moral distress ' from ongoing shortages.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - December 1, 2023 Category: Drugs & Pharmacology Tags: Hematology-Oncology News Source Type: news
Patient Support Programs Need Transparency, Researchers Say Patient Support Programs Need Transparency, Researchers Say
A broad overview of patient-support programs should be a ' first step ' in weighing whether these programs deliver value for patients in return for their cost to the health system, says a researcher.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - November 30, 2023 Category: Drugs & Pharmacology Tags: Pharmacist News Source Type: news
Abatacept Slows Progression to RA, Phase 2b Trial Finds Abatacept Slows Progression to RA, Phase 2b Trial Finds
The study was conducted at 28 sites in the United Kingdom and three in the Netherlands.MDedge News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - November 28, 2023 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news
